Sotera Health Q2 net income surges 574% to $53.6M on 9.2% revenue growth, lower rates

Filed August 6, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 8, 2025 · ~2 min read

Key Changes

• high

  Net income jumped 574% to $53.6M from $8.0M in Q2 2025, driven by 9.2% revenue growth to $321.4M, a 15.4% drop in interest expense (debt refinancing cut rates 152bp to 6.03%), and a $6.3M reduction in intangible amortization after May 2025 full amortization.

  MD&A: Results of Operations verify on EDGAR →
• high

  Securities litigation and insurance-coverage litigation removed from material legal proceedings disclosure; only ethylene oxide litigation remains. New Mexico EO lawsuit settled June 24, 2026 for an immaterial amount with dismissal with prejudice.

  Legal Proceedings / Notes: Commitments and Contingencies verify on EDGAR →
• high

  Georgia EO litigation: Court of Appeals vacated trial court's general-causation ruling in October 2025, remanded with instructions to apply proper expert-admissibility standard; trial court then granted summary judgment for defendants in five pool cases March 2026. All proceedings stayed pending appeals.

  Notes: Commitments and Contingencies verify on EDGAR →